STEPHANIE DAVIS: Open Payments
NPI 1033402151 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,571 in 169 payments from 22 companies in 2025. Trend: 2023 $7,503 · 2024 $13,343 · 2025 $6,571
Consulting: $3,525Food & beverage: $2,588Travel & lodging: $378Education: $80
| Company | Payments | Amount |
|---|---|---|
| Eli Lilly and Company | 4 | $3,228 |
| ABBVIE INC. | 36 | $1,150 |
| UCB, Inc. | 14 | $340 |
| Lilly USA, LLC | 11 | $281 |
| Galderma Laboratories, L.P. | 27 | $220 |
| E.R. Squibb & Sons, L.L.C. | 8 | $192 |
| Regeneron Healthcare Solutions, Inc. | 8 | $186 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $158 |
| PFIZER INC. | 13 | $157 |
| Janssen Biotech, Inc. | 11 | $148 |
Products named: EBGLYSS, SKYRIZI, Bimzelx, RINVOQ, DUPIXENT, NEMLUVIO, Sotyktu, TREMFYA.
Industry payments across SC — which companies pay providers there.
